RBOT vicarioussurgical.com: Debt to Book Capitalization Ratio

Official company branding of Vicarious Surgical Corp (RBOT)

Environmental risks are minimized through energy-efficient robots that reduce the volume of medical waste. The ratio of financial debt to book capitalization confirms the stability of the structure, where the indicator is maintained at 0.93. Stability is bolstered by unique human-like motor systems for single-incision operations, while protection against macroeconomic crises is ensured by the constant demand for high-tech medical care for Vicarious Surgical Inc. (RBOT).

Vicarious Surgical Inc - RBOT Debts to Book Capitalization (period 07/04/2022 - 03/07/2026)
Product sample of Vicarious Surgical Inc

This indicator determines the proportion of borrowed funds within the overall equity structure of the company. For Vicarious Surgical Inc. (RBOT), which is currently in the clinical trial stage, this parameter reflects the balance between external financing and financial autonomy. By analyzing the ratio of total debt to book value of equity, an investor can assess the business's resilience to rising interest rates. A reduction in leverage confirms a conservative approach to borrowing, which is critically important when preparing infrastructure for commercial launch.

Competing companies

Debts to Book Capitalization DXCM (DexCom, Inc.)|penumbrainc.com (PEN) - Debts to Book Value|NOVT - Debt to Book Capitalization Ratio|Debt to Net Assets Ratio HAE (Haemonetics Corp)|INSP: Debts to Book Capitalization|Procept (PRCT) - Debts to Book Capitalization|Debt to Book Capitalization Ratio CONMED Corporation|pulsebiosciences.com - Debts to Book Capitalization Ratio|Debts to Book Capitalization INMD|PMI - Debts to Book Value|Surmodics Corp - Debt to Book Value|Debts to Book Capitalization Senseonics SENS|NPCE: Debt to Book Value|Tactile Systems Technology - Debt to Book Capital|SNWV: Debts to Book Capitalization|OM - Debts to Net Assets|ELMD (SmartVest) - Debts to Book Capitalization|Debt to Book Value LENSAR Inc (LNSR)|Debt to Book Value RCEL (AVITA Medical, Inc.)|PROF (profoundmedical.com) - Debt to Net Assets Ratio|Debt to Book Capitalization Ratio Baird Medical BDMD|EDAP - Debt to Book Value|Bovie Medical - Debts to Book Capitalization|Debts to Book Value IceCure Medical Ltd|LUNG: Debts to Book Capitalization|Debt to Book Value Ratio TELA|CTSO (CytoSorbents Corp) - Debts to Book Capitalization|Sensus Healthcare Inc (SRTS) - Debts to Net Assets|Debts to Book Capitalization ZYXI|Debt to Book Value electrocore.com ECOR|Debts to Book Capitalization IINN (Inspira Technologies)|Debts to Book Capitalization seastarmedical.com ICU|IRIX - Debt to Book Capitalization Ratio|INBS: Debt to Book Capitalization Ratio|XAIR (beyondair.net) - Debt to Book Value|Profusa, Inc - Debt to Net Assets Ratio|SSKN (STRATA Skin Sciences Inc.) - Debts to Book Capitalization|Debts to Book Value glucotrack.com GCTK|Debt to Book Capitalization Ratio NanoVibronix (NAOV)|Venus Concept Inc (VERO) - Debt to Net Assets|CHF Solutions - Debt to Book Value|Debts to Book Capitalization Aethlon Medical Corp AEMD|TransEnterix - Debts to Book Capitalization|Debts to Net Assets avinger.com AVGR|Biosig Technologies (BSGM) - Debt to Book Capitalization Ratio|Debts to Book Capitalization Ratio CUTR (Cutera Inc.)|Debt to Book Capitalization Ratio Know Labs Corp|Debt to Book Value Inari Medical Corp (NARI)|Debts to Book Capitalization NVRO|RSLS - Debts to Book Value|Debt to Book Capitalization Ratio Silk Road Medical SILK